- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Childhood Sexual Abuse Litigation
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Domestic and International Arbitration
- Ediscovery
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Restructuring and Business Bankruptcy
- Wealth Planning, Administration, and Disputes
- Litigation Support Services
-
December 4, 2019State of Minnesota Sues JUUL
-
November 26, 2019Minnesota Lawyer Honors Two Robins Kaplan Attorneys as 2019 Attorneys of the Year
-
November 21, 2019Firm, Attorney Stacey Slaughter Recognized by National Law Journal
-
December 11, 2019Mid-Minnesota Legal Aid Associates’ Campaign Kickoff
-
December 11, 2019Minnesota ICON Honors Award Ceremony
-
December 12, 2019Using IPRs to Challenge and Defend Patents: Standing, Serial IPRs, Unintended Consequences
-
November 2019CLASS ACTION: Experts weigh in on significant class action developments
-
November 15, 20192019 Case Developments: Are Massachusetts Insurers Required To Be Perfect In An Imperfect World?
-
November 15, 2019Artificial Intelligence v. General Data Protection Regulation: Complex Risks in Changing Times
Generic Launches Q3 2012
Reference Listed Drug, NDA Holder, Generic Drug Name, ANDA Applicant(s), Indication and Launch Date
November 11, 2012

Reference Listed Drug |
NDA Holder |
Generic Drug Name |
ANDA Applicant(s) |
Indication |
Launch Date |
Boniva |
GlaxoSmithKline/Roche |
ibandronate sodium tablets |
Dr. Reddy's Labs |
Osteoporosis |
July 2, 2012 |
Lescol |
Novartis |
fluvastatin capsules, USP |
Teva |
Antilipemic/statins |
Jul. 2, 2012 |
Clarinex |
Schering-Plough |
desloratadine tablets |
Mylan |
Allergy medication |
July 3, 2012 |
Lithobid Tablets |
Noven Therapeutic |
lithobid carbonate extended release tablets USP |
Mylan |
Bipolar disorder |
Jul. 3, 2012 |
Plan B One-Step |
Teva |
levonorgestrel tablets |
Watson Labs |
Prevention of pregnancy |
Jul. 13, 2012 |
Ritalin LA Extended Release Capsules |
Novartis |
methylphenidate hydrochloride extended release capsules |
Teva |
ADHD |
July 16, 2012 |
Lipitor |
Pfizer |
atorvastatin calcium tabs |
Dr. Reddy's Labs |
High cholesterol |
Jul. 18, 2012 |
Oxacillin Sodium ADD-Vantage |
Sandoz |
oxacillin for injection |
Sagent Pharm |
Antibiotic |
Jul. 24, 2012 |
Sporanox |
Janssen Pharmaceutical |
itraconazole capsules |
Mylan |
Fungal infections in the lungs, blastomycosis, histoplasmosis and aspergillosis |
Jul. 27, 2012 |
Oxycodone |
Lehigh Valley |
oxycodone hydrochloride |
Coastal Pharmaceuticals |
Pain management |
Jul. 30, 2012 |
Methotrexate sodium |
Quad Pharms |
methotrexate injection |
Teva |
Antineoplastics |
Jul. 31, 2012 |
Dovonex |
LEO Pharma |
calcipotriene cream |
Sandoz |
Plaque psoriasis |
Aug. 3, 2012 |
Singulair Tablets and Singulair Chewable Tablets |
Merck |
montelukast sodium tablets and montelukast sodium chewable tablets |
Roxane |
Asthma and allergies |
Aug. 3, 2012 |
Singulair Tablets and Singulair Chewable Tablets |
Merck |
montelukast sodium tablets and montelukast sodium chewable tablets |
Teva |
Asthma and allergies |
Aug. 3, 2012 |
Amidate Injection |
Hospira |
etomidate injection USP |
Mylan |
Induction of general anesthesia |
Aug. 6, 2012 |
Singulair Tablets and Singulair Chewable Tablets |
Merck |
montelukast sodium tablets and montelukast sodium chewable tablets |
Sandoz |
Asthma and allergies |
Aug. 6, 2012 |
Singulair Tablets and Singulair Chewable Tablets |
Merck |
montelukast sodium tablets and montelukast sodium chewable tablets |
Endo Pharmaceuticals |
Asthma and allergies |
Aug. 6, 2012 |
Singulair Tablets and Singulair Chewable Tablets |
Merck |
montelukast sodium tablets and montelukast sodium chewable tablets |
Glenmark Generics |
Asthma and allergies |
Aug. 6, 2012 |
Singulair Tablets and Singulair Chewable Tablets |
Merck |
montelukast sodium tablets and montelukast sodium chewable tablets |
Mylan |
Asthma and allergies |
Aug. 7, 2012 |
Singulair Tablets and Singulair Chewable Tablets |
Merck |
montelukast sodium tablets and montelukast sodium chewable tablets |
Dr. Reddy's Labs |
Asthma and allergies |
Aug. 7, 2012 |
Morphine Sulfate |
Roxane |
morphine sulfate |
Perrigo |
Opioid analgesic for pain management |
Aug. 8, 2012 |
Clobex Shampoo |
Galderma Labs |
clobetasol propionate shampoo |
Perrigo |
Scalp psoriasis |
Aug, 9, 2012 |
Elaxotin |
Sanofi Aventis |
oxaliplatin for injection |
Hospira |
Chemotherapy |
Aug. 9, 2012 |
Eloxatin |
Sanofi Aventis |
oxaliplatin for injection |
Sagent Pharm |
Stage II colon cancer |
Aug. 9, 2012 |
Lithium Carbonate |
Roxane |
lithium carbonate extended release tablets USP |
Mylan |
Manic episodes of manic depressive illness |
Aug. 10, 2012 |
Provigil Tablets |
Cephalon |
modafinil tablets USP |
Mylan |
Improve wakefulness |
Aug. 10, 2012 |
Eloxatin |
Sanofi Aventis |
oxaliplatin injection |
Teva |
Antineoplastics |
Aug. 13, 2012 |
Uroxatral |
Sanofi Aventis |
alfuzosin hydrochloride |
Wockhardt |
Benign prostatic hyperplasia and enlarged prostate |
Aug. 14, 2012 |
Plavix |
Bristol-Myers Squibb |
clopidogrel bisulfate |
Wockhardt |
Clot-buster |
Aug. 16, 2012 |
Actoplus Met Tablets |
Takeda Pharmaceutical Company |
pioglitazone hydrochloride and metformin hydrochloride |
Mylan |
Anti-diabetic |
Aug. 17, 2012 |
Actos |
Takeda Pharmaceutical Company |
pioglitazone hydrochloride tablet |
Teva |
Anti-diabetic |
Aug. 17, 2012 |
Actos |
Takeda Pharmaceutical Company |
pioglitazone hydrochloride tablet |
Ranbaxy |
Anti-diabetic |
Aug. 17, 2012 |
Actos Tablets |
Takeda Pharmaceutical Company |
pioglitazone hydrochloride tablet |
Mylan |
Anti-diabetic |
Aug. 17, 2012 |
Actosplus Met |
Takeda Pharmaceutical Company |
pioglitazone hydrochloride and metformin hydrochloride |
Teva |
Anti-diabetic |
Aug. 17, 2012 |
Xopenex |
Sunovion Pharmaceuticals |
levalbuterol hydrochloride inhalation solution |
Watson Labs |
Bronchospasm |
Aug. 20, 2012 |
Xopenex |
Sunovion Pharmaceuticals |
levalbuterol hydrochloride inhalation solution |
Prasco |
Bronchospasm |
Aug. 20, 2012 |
Plendil |
AstraZeneca |
felodipine |
Wockhardt |
Anti-hypertension |
Aug. 21, 2012 |
FazaClo |
Jazz Pharmaceuticals |
clozapine tablets |
Teva |
Anti-psychotic |
Aug. 29, 2012 |
Wellbutrin |
GlaxoSmithKline |
bupropion hydrochloride |
Wockhardt |
Anti-depressant |
Sept. 3, 2012 |
Zofran |
Glaxo Group Limited Corporation |
ondansetron for injection |
Sagent Pharm |
Antiemetic for emetogenic cancer chemotherapy |
Sept. 10, 2012 |
Toprol-XL |
AstraZeneca |
metoprolol succinate |
Dr. Reddy's Labs |
Angina and hypertension |
Sept. 11, 2012 |
Prevacid |
Takeda |
lansoprazole |
Wockhardt |
anti-ulcer |
Sept. 17, 2012 |
Amoxil |
GlaxoSmithKline |
amoxicillin tablets |
Dr. Reddy's Labs |
Antibiotic |
Sept. 20, 2012 |
Antivert Tablets |
Pfizer |
meclizine hydrochloride tablets USP |
Mylan |
Nausea and vomiting, and dizziness associated with motion sickness |
Sept. 21, 2012 |
Diovan and Diovan HCT |
Novartis |
valsartan and hydrochlorothiazide tablets |
Sandoz |
High blood pressure |
Sept. 21, 2012 |
Coumadin |
Bristol-Myers Squibb |
warfarin sodium tablets |
InvaGen |
Venous thrombosis |
Sept. 26, 2011 |
Metedete CD/Ritalin LA |
UCB/Novartis |
methylphenidate hydrochloride extended release capsules |
Teva |
ADHD |
Sept. 27, 2012 |
Avapro and Avalide |
Sanofi Aventis |
irbesartan tablets USP and hydrochlorothiazide tablets USP |
Mylan |
Hypertension |
Sept. 28, 2012 |
Vancocin |
Quad Pharms |
vancomycin hydrochloride for injection |
Sagent Pharm |
Antibiotic |
Sept. 28, 2012 |
Related Professionals
Related Publications
Related News
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.